New: NCI-funded clinical trial search
Mednet Logo
CommunityRheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

What is your preferred steroid sparing agent in the treatment of Sjögren associated LIP?

2 Answers

Mednet MemberInvited Expert
Pulmonology · Massachusetts General Hospital

There is unfortunately very limited data comparing the efficacy of various steroid-sparing agents for the treatment of connective tissue disease-related ILD, and no large prospective studies have specifically addressed the ideal approach for patients with underlying Sjogrens. Mycophenolate and azath...

How would you approach the management of a patient with tophaceous gout who consistently has a serum uric acid under 5 on allopurinol but continues to experience gout flares?

2
2 Answers

Mednet MemberInvited Expert
Rheumatology · National institues of Health

I have a slightly different take on this question than Dr. @Dr. First Last. We don’t know from the question when allopurinol was started, what the current dose is or if the patient’s gout is tophaceous. Flares are commonly seen for several months after oral uric acid lowering therapy (ULT) is initia...

How would you approach a patient with elevated CPK in the 500-1000 range with no weakness on exam or myositis on MRI but with positive HMGCoA ab?

1 Answers

Mednet MemberInvited Expert
Rheumatology · University of Pittsburgh

No treatment but follow closely for weakness and muscle enzyme further elevation. If CK starts to go up and doubles and triples, or weakness start, then start treatment as soon as possible.

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

Would a surgical decompression be indicated in a patient with amyloidosis and severe median neuropathy at the wrist?

1 Answers

Mednet MemberInvited Expert
Neurology · University of Minnesota

Yes, of course, if the median neuropathy is symptomatic. I am not aware of any literature suggesting lower rates of success with carpal tunnel release surgery in patients with various amyloidosis subtypes compared to non-amyloid CTS.

What is your approach to treating premenopausal woman with OI with a new compression fracture?

1
2 Answers

Mednet MemberInvited Expert
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

Young women with idiopathic premenopausal osteoporosis likely have low bone formation. I was not told her BMD but I will assume it is low. An antiresorptive does not make much sense because she is producing enough estrogen to keep her cycles going. There has been some published data with the use o...

Is there practical utility from obtaining CSF autoantibodies in patients with suspected neuropsychiatric systemic lupus erythematosus?

1 Answers

Mednet MemberInvited Expert
Neurology · Yale University School of Medicine

I typically obtain serum and CSF autoimmune encephalopathy panels based on a patient's APE2 score. A score of 4 or more is predictive of having positive serum or CSF antibodies and can be applied to patients with neuropsychiatric lupus and help stratify who to test. I would start the workup with MRI...

How do you decide when to try stopping hydroxychloroquine in patients with erosive osteoarthritis?

1
1 Answers

Mednet MemberInvited Expert
Rheumatology · NYU Langone Health

As we lack any peer-reviewed evidence that hydroxychloroquine (HCQ) effectively and significantly helps with erosive osteoarthritis, I would stop the drug if there was no relief within 2 months (if I had started it for a patient). While HCQ (and other DMARDs) are often used empirically with these er...

How do you approach treatment of PMR in a patient who has had avascular necrosis of the hip after starting steroids?

1 Answers

Mednet MemberInvited Expert
Rheumatology · Harvard Medical School

In this clinical scenario, I strongly advise avoidance of steroids. The data looks promising for using anti-IL-6 therapy in PMR. I don’t think it should be considered first-line therapy for our patients yet but should be reserved for those who have major contraindications or issues regarding the use...

How would you manage warfarin in a patient with APLS and alcoholic cirrhosis?

1 Answers

Mednet MemberInvited Expert
Rheumatology · Hackensack University Medical Center

This is an interesting and challenging question that would require a case-by-case review by a team of rheumatologists, hematologists, and hepatologists, as well as an in-depth discussion of the potential risks and benefits with the patient. This reference, O'Leary et al., PMID 30986390, provides a g...

For a patient with osteopenia or osteoporosis, how long can intravenous zoledronic acid be maintained if there are not adverse events?

2
1 Answers

Mednet Member
Rheumatology · NYU Langone

I generally prescribe Zoledronate annually for three years for patients with osteoporosis who are at increased fracture risk. I will occasionally add an additional treatment 18-24 months after the third infusion if there has been a positive response to the original treatment regimen and I feel that ...